<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-10-25" version="145">
<accession>P53816</accession>
<accession>B2R7Q4</accession>
<accession>B7XAK5</accession>
<accession>Q3SYI3</accession>
<accession>Q9HDD1</accession>
<name>PA216_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="19">HRAS-like suppressor 3</fullName>
<shortName evidence="19">HRSL3</shortName>
<ecNumber evidence="9 11 12 13 14">3.1.1.32</ecNumber>
<ecNumber evidence="9 11 12 13 14">3.1.1.4</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="4">Adipose-specific phospholipase A2</fullName>
<shortName evidence="4">AdPLA</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="24">Group XVI phospholipase A1/A2</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="21">H-rev 107 protein homolog</fullName>
<shortName evidence="21">H-REV107</shortName>
<shortName evidence="21">HREV107-1</shortName>
</alternativeName>
<alternativeName>
<fullName>HRAS-like suppressor 1</fullName>
</alternativeName>
<alternativeName>
<fullName>HREV107-3</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="18">Renal carcinoma antigen NY-REN-65</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="24">PLA2G16</name>
<name type="synonym" evidence="20">HRASLS3</name>
<name type="synonym" evidence="21">HREV107</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="1305" last="1312">
<title>Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.</title>
<authorList>
<person name="Husmann K."/>
<person name="Sers C."/>
<person name="Fietze E."/>
<person name="Mincheva A."/>
<person name="Lichter P."/>
<person name="Schafer R."/>
</authorList>
<dbReference type="PubMed" id="9771974"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202060"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1999-08" db="EMBL/GenBank/DDBJ databases">
<title>Human cDNA encoding H-REV107 protein homolog.</title>
<authorList>
<person name="Kato S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="5155" last="5163">
<title>hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors.</title>
<authorList>
<person name="Siegrist S."/>
<person name="Feral C."/>
<person name="Chami M."/>
<person name="Solhonne B."/>
<person name="Mattei M.G."/>
<person name="Rajpert-De Meyts E."/>
<person name="Guellaen G."/>
<person name="Bulle F."/>
</authorList>
<dbReference type="PubMed" id="11526504"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204658"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1791" first="1114" last="1124">
<title>Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes.</title>
<authorList>
<person name="Uyama T."/>
<person name="Jin X.H."/>
<person name="Tsuboi K."/>
<person name="Tonai T."/>
<person name="Ueda N."/>
</authorList>
<dbReference type="PubMed" id="19615464"/>
<dbReference type="DOI" id="10.1016/j.bbalip.2009.07.001"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
<title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gordan J.D."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Bander N.H."/>
<person name="Jongeneel C.V."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Jaeger E."/>
<person name="Knuth A."/>
<person name="Chen Y.-T."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="10508479"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19991112)83:4&lt;456::AID-IJC4>3.0.CO;2-5"/>
</citation>
<scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
<source>
<tissue>Renal cell carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2829" last="2839">
<title>The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.</title>
<authorList>
<person name="Sers C."/>
<person name="Husmann K."/>
<person name="Nazarenko I."/>
<person name="Reich S."/>
<person name="Wiechen K."/>
<person name="Zhumabayeva B."/>
<person name="Adhikari P."/>
<person name="Schroder K."/>
<person name="Gontarewicz A."/>
<person name="Schafer R."/>
</authorList>
<dbReference type="PubMed" id="11973642"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205377"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="J. Cell Sci." volume="120" first="1393" last="1404">
<title>Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells.</title>
<authorList>
<person name="Nazarenko I."/>
<person name="Schafer R."/>
<person name="Sers C."/>
</authorList>
<dbReference type="PubMed" id="17374643"/>
<dbReference type="DOI" id="10.1242/jcs.000018"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PPP2R1A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-23 AND CYS-113</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Lipid Res." volume="50" first="685" last="693">
<title>The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type.</title>
<authorList>
<person name="Uyama T."/>
<person name="Morishita J."/>
<person name="Jin X.H."/>
<person name="Okamoto Y."/>
<person name="Tsuboi K."/>
<person name="Ueda N."/>
</authorList>
<dbReference type="PubMed" id="19047760"/>
<dbReference type="DOI" id="10.1194/jlr.M800453-JLR200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Nat. Med." volume="15" first="159" last="168">
<title>AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency.</title>
<authorList>
<person name="Jaworski K."/>
<person name="Ahmadian M."/>
<person name="Duncan R.E."/>
<person name="Sarkadi-Nagy E."/>
<person name="Varady K.A."/>
<person name="Hellerstein M.K."/>
<person name="Lee H.Y."/>
<person name="Samuel V.T."/>
<person name="Shulman G.I."/>
<person name="Kim K.H."/>
<person name="de Val S."/>
<person name="Kang C."/>
<person name="Sul H.S."/>
</authorList>
<dbReference type="PubMed" id="19136964"/>
<dbReference type="DOI" id="10.1038/nm.1904"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="Nature" volume="541" first="412" last="416">
<title>PLA2G16 represents a switch between entry and clearance of Picornaviridae.</title>
<authorList>
<person name="Staring J."/>
<person name="von Castelmur E."/>
<person name="Blomen V.A."/>
<person name="van den Hengel L.G."/>
<person name="Brockmann M."/>
<person name="Baggen J."/>
<person name="Thibaut H.J."/>
<person name="Nieuwenhuis J."/>
<person name="Janssen H."/>
<person name="van Kuppeveld F.J."/>
<person name="Perrakis A."/>
<person name="Carette J.E."/>
<person name="Brummelkamp T.R."/>
</authorList>
<dbReference type="PubMed" id="28077878"/>
<dbReference type="DOI" id="10.1038/nature21032"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF CYS-113</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="FEBS Lett." volume="584" first="4222" last="4226">
<title>Solution structure of the N-terminal catalytic domain of human H-REV107 -- a novel circular permutated NlpC/P60 domain.</title>
<authorList>
<person name="Ren X."/>
<person name="Lin J."/>
<person name="Jin C."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="20837014"/>
<dbReference type="DOI" id="10.1016/j.febslet.2010.09.015"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-125</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="23790" last="23807">
<title>Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins.</title>
<authorList>
<person name="Golczak M."/>
<person name="Kiser P.D."/>
<person name="Sears A.E."/>
<person name="Lodowski D.T."/>
<person name="Blaner W.S."/>
<person name="Palczewski K."/>
</authorList>
<dbReference type="PubMed" id="22605381"/>
<dbReference type="DOI" id="10.1074/jbc.M112.361550"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 1-132</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVE SITE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="35260" last="35274">
<title>Structure/Function relationships of adipose phospholipase A2 containing a cys-his-his catalytic triad.</title>
<authorList>
<person name="Pang X.Y."/>
<person name="Cao J."/>
<person name="Addington L."/>
<person name="Lovell S."/>
<person name="Battaile K.P."/>
<person name="Zhang N."/>
<person name="Rao J.L."/>
<person name="Dennis E.A."/>
<person name="Moise A.R."/>
</authorList>
<dbReference type="PubMed" id="22923616"/>
<dbReference type="DOI" id="10.1074/jbc.M112.398859"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 1-134</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="Nat. Chem. Biol." volume="11" first="26" last="32">
<title>LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3.</title>
<authorList>
<person name="Golczak M."/>
<person name="Sears A.E."/>
<person name="Kiser P.D."/>
<person name="Palczewski K."/>
</authorList>
<dbReference type="PubMed" id="25383759"/>
<dbReference type="DOI" id="10.1038/nchembio.1687"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-38 AND 59-129</scope>
<scope>MUTAGENESIS OF 39-PRO--LYS-57</scope>
</reference>
<comment type="function">
<text evidence="4 8 9 11 12 13 14 15">Lipid-modifying enzyme that acts as major regulator of adipocyte lipolysis by catalyzing the release of fatty acids from phospholipids in adipose tissue (PubMed:19615464, PubMed:19047760, PubMed:20837014, PubMed:22605381, PubMed:22923616). Shows phospholipase A1 and A2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE) (PubMed:19615464, PubMed:19047760, PubMed:20837014, PubMed:22605381, PubMed:22923616). For most substrates, phospholipase A1 activity is much higher than phospholipase A2 activity (PubMed:19047760). Phospholipase activity causes decreased intracellular levels of ether-type lipids, affecting peroxisome metabolism (By similarity). May also have acyltransferase activity: catalyzes both N-acylation of phosphatidylethanolamine to form N-acyl-phosphatidylethanolamine and O-acylation of lyso-phosphatidylcholines to form phosphatidylcholines (PubMed:22605381, PubMed:25383759). The relevance of acyltransferase activity in vivo is however unclear and would require additional evidences (PubMed:22605381, PubMed:25383759). Also has weak lysophospholipase activity (By similarity).</text>
</comment>
<comment type="function">
<text evidence="16">(Microbial infection) Acts as a host factor for picornaviruses: required during early infection to promote viral genome release into the cytoplasm (PubMed:28077878). May act as a cellular sensor of membrane damage at sites of virus entry, which relocalizes to sites of membrane rupture upon virus unfection (PubMed:28077878). Facilitates safe passage of the RNA away from LGALS8, enabling viral genome translation by host ribosome (PubMed:28077878). May also be involved in initiating pore formation, increasing pore size or in maintaining pores for genome delivery (PubMed:28077878). The lipid-modifying enzyme activity is required for this process (PubMed:28077878).</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 11 12 13 14">Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 11 12 13 14">Phosphatidylcholine + H(2)O = 2-acylglycerophosphocholine + a carboxylate.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="11">300 uM for dipalmitoyl-PC</KM>
<Vmax evidence="11">2.57 umol/min/mg enzyme with dipalmitoyl-PC as substrate</Vmax>
<Vmax evidence="11">267 nmol/min/mg enzyme with dipalmitoyl-PE as substrate</Vmax>
</kinetics>
<phDependence>
<text evidence="11">Optimum pH is 9.</text>
</phDependence>
</comment>
<comment type="subunit">
<text evidence="8">Interacts with PPP2R1A; this interaction might decrease PP2A activity.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746318"/>
<interactant intactId="EBI-302388">
<id>P30153</id>
<label>PPP2R1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746318"/>
<interactant intactId="EBI-741480">
<id>Q9UMX0</id>
<label>UBQLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746318"/>
<interactant intactId="EBI-10173939">
<id>Q9UMX0-2</id>
<label>UBQLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="23">Membrane</location>
<topology evidence="5">Single-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
<location evidence="4">perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Peroxisome membrane</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="6 7 10 11 17">Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. Highly expressed in white adipose tissue (PubMed:19136964).</text>
</comment>
<comment type="induction">
<text evidence="7">By IFNG and IRF1.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the H-rev107 family.</text>
</comment>
<dbReference type="EC" id="3.1.1.32" evidence="9 11 12 13 14"/>
<dbReference type="EC" id="3.1.1.4" evidence="9 11 12 13 14"/>
<dbReference type="EMBL" id="X92814">
<property type="protein sequence ID" value="CAA63423.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030814">
<property type="protein sequence ID" value="BAB08108.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF317086">
<property type="protein sequence ID" value="AAL26892.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB439591">
<property type="protein sequence ID" value="BAH08749.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313075">
<property type="protein sequence ID" value="BAG35901.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471076">
<property type="protein sequence ID" value="EAW74158.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001387">
<property type="protein sequence ID" value="AAH01387.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC103807">
<property type="protein sequence ID" value="AAI03808.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8047.1"/>
<dbReference type="RefSeq" id="NP_001121675.1">
<property type="nucleotide sequence ID" value="NM_001128203.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009000.2">
<property type="nucleotide sequence ID" value="NM_007069.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006718489.1">
<property type="nucleotide sequence ID" value="XM_006718426.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.502775"/>
<dbReference type="PDB" id="2KYT">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-125"/>
</dbReference>
<dbReference type="PDB" id="4DOT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A=1-132"/>
</dbReference>
<dbReference type="PDB" id="4FA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=1-134"/>
</dbReference>
<dbReference type="PDB" id="4Q95">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=2-38, A/B=59-129"/>
</dbReference>
<dbReference type="PDBsum" id="2KYT"/>
<dbReference type="PDBsum" id="4DOT"/>
<dbReference type="PDBsum" id="4FA0"/>
<dbReference type="PDBsum" id="4Q95"/>
<dbReference type="ProteinModelPortal" id="P53816"/>
<dbReference type="SMR" id="P53816"/>
<dbReference type="BioGrid" id="116317">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="IntAct" id="P53816">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="MINT" id="MINT-1461468"/>
<dbReference type="STRING" id="9606.ENSP00000320337"/>
<dbReference type="SwissLipids" id="SLP:000001077"/>
<dbReference type="iPTMnet" id="P53816"/>
<dbReference type="PhosphoSitePlus" id="P53816"/>
<dbReference type="BioMuta" id="PLA2G16"/>
<dbReference type="DMDM" id="20141767"/>
<dbReference type="EPD" id="P53816"/>
<dbReference type="MaxQB" id="P53816"/>
<dbReference type="PaxDb" id="P53816"/>
<dbReference type="PeptideAtlas" id="P53816"/>
<dbReference type="PRIDE" id="P53816"/>
<dbReference type="DNASU" id="11145"/>
<dbReference type="Ensembl" id="ENST00000323646">
<property type="protein sequence ID" value="ENSP00000320337"/>
<property type="gene ID" value="ENSG00000176485"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415826">
<property type="protein sequence ID" value="ENSP00000389124"/>
<property type="gene ID" value="ENSG00000176485"/>
</dbReference>
<dbReference type="GeneID" id="11145"/>
<dbReference type="KEGG" id="hsa:11145"/>
<dbReference type="UCSC" id="uc001nxh.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="11145"/>
<dbReference type="DisGeNET" id="11145"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000176485.10"/>
<dbReference type="GeneCards" id="PLA2G16"/>
<dbReference type="HGNC" id="HGNC:17825">
<property type="gene designation" value="PLA2G16"/>
</dbReference>
<dbReference type="HPA" id="HPA058997"/>
<dbReference type="MIM" id="613867">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P53816"/>
<dbReference type="OpenTargets" id="ENSG00000176485"/>
<dbReference type="PharmGKB" id="PA164724584"/>
<dbReference type="eggNOG" id="ENOG410IW0Y">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111TDD">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000013327"/>
<dbReference type="HOGENOM" id="HOG000293227"/>
<dbReference type="InParanoid" id="P53816"/>
<dbReference type="KO" id="K16817"/>
<dbReference type="OMA" id="HVNNKHD"/>
<dbReference type="OrthoDB" id="EOG091G08MK"/>
<dbReference type="PhylomeDB" id="P53816"/>
<dbReference type="TreeFam" id="TF330836"/>
<dbReference type="Reactome" id="R-HSA-1482788">
<property type="pathway name" value="Acyl chain remodelling of PC"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482801">
<property type="pathway name" value="Acyl chain remodelling of PS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482839">
<property type="pathway name" value="Acyl chain remodelling of PE"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482922">
<property type="pathway name" value="Acyl chain remodelling of PI"/>
</dbReference>
<dbReference type="SIGNOR" id="P53816"/>
<dbReference type="ChiTaRS" id="PLA2G16">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="HRASLS3"/>
<dbReference type="GenomeRNAi" id="11145"/>
<dbReference type="PRO" id="PR:P53816"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000176485"/>
<dbReference type="CleanEx" id="HS_PLA2G16"/>
<dbReference type="ExpressionAtlas" id="P53816">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P53816">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005778">
<property type="term" value="C:peroxisomal membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005777">
<property type="term" value="C:peroxisome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052740">
<property type="term" value="F:1-acyl-2-lysophosphatidylserine acylhydrolase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0008970">
<property type="term" value="F:phosphatidylcholine 1-acylhydrolase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052739">
<property type="term" value="F:phosphatidylserine 1-acylhydrolase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004623">
<property type="term" value="F:phospholipase A2 activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0102567">
<property type="term" value="F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0102568">
<property type="term" value="F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0016746">
<property type="term" value="F:transferase activity, transferring acyl groups"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046485">
<property type="term" value="P:ether lipid metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016042">
<property type="term" value="P:lipid catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045786">
<property type="term" value="P:negative regulation of cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007031">
<property type="term" value="P:peroxisome organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036151">
<property type="term" value="P:phosphatidylcholine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036152">
<property type="term" value="P:phosphatidylethanolamine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036149">
<property type="term" value="P:phosphatidylinositol acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036150">
<property type="term" value="P:phosphatidylserine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008654">
<property type="term" value="P:phospholipid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006644">
<property type="term" value="P:phospholipid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904177">
<property type="term" value="P:regulation of adipose tissue development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006641">
<property type="term" value="P:triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR007053">
<property type="entry name" value="LRAT-like_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF04970">
<property type="entry name" value="LRAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0442">Lipid degradation</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0576">Peroxisome</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="HRAS-like suppressor 3" id="PRO_0000152484">
<location>
<begin position="1"/>
<end position="162"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="1"/>
<end position="132"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="133"/>
<end position="155"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="5">
<location>
<begin position="156"/>
<end position="162"/>
</location>
</feature>
<feature type="active site" evidence="12 13 14">
<location>
<position position="23"/>
</location>
</feature>
<feature type="active site" evidence="12 13 14">
<location>
<position position="35"/>
</location>
</feature>
<feature type="active site" description="Acyl-thioester intermediate" evidence="12 13 14">
<location>
<position position="113"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PPP2R1A-binding." evidence="8">
<original>H</original>
<variation>A</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces a major structural rearrangement accompanied by domain-swapping dimerization and changes in substrate-specificity." evidence="15">
<original>PSEVAGAGAASVMSALTDK</original>
<variation>DILLALTDDMGRTQKVVSNKRLILGVIVKV</variation>
<location>
<begin position="39"/>
<end position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PPP2R1A-binding. Impaired ability to act as a host factor for picornaviruses." evidence="8 16">
<original>C</original>
<variation>S</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA63423 and 4; BAH08749." ref="1 4" evidence="22">
<original>S</original>
<variation>T</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="13"/>
<end position="18"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="21"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="32"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="41"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="45"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="59"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="65"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="72"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="89"/>
<end position="98"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="103"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="110"/>
<end position="122"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KYT"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DOT"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Q95"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8R3U1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11526504"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11973642"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17374643"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19047760"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19136964"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19615464"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20837014"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22605381"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22923616"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25383759"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28077878"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9771974"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10508479"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17374643"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22605381"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9771974"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22605381"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:17825"/>
</source>
</evidence>
<sequence length="162" mass="17937" checksum="3565BFC756A6DA3C" modified="2002-01-31" version="2">
MRAPIPEPKPGDLIEIFRPFYRHWAIYVGDGYVVHLAPPSEVAGAGAASVMSALTDKAIV
KKELLYDVAGSDKYQVNNKHDDKYSPLPCSKIIQRAEELVGQEVLYKLTSENCEHFVNEL
RYGVARSDQVRDVIIAASVAGMGLAAMSLIGVMFSRNKRQKQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>